Search Results - V. V. Kashtalap

Refine Results
  1. 1
    Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor)

    Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor) by V. V. Kashtalap

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation)

    Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation) by V. V. Kashtalap

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Endothelial protective effect of pitavastatin

    Endothelial protective effect of pitavastatin by A. S. Berns, V. V. Kashtalap

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Single-pill combination of indapamide and perindopril: potential of practical application

    Single-pill combination of indapamide and perindopril: potential of practical application by A. M. Kochergina, V. V. Kashtalap

    Published 2024-04-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Non-ST segment elevation myocardial infarction: results of 2021−2022

    Non-ST segment elevation myocardial infarction: results of 2021−2022 by O. L. Barbarash, V. V. Kashtalap

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban

    Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban by O. L. Barbarash, V. V. Kashtalap

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS

    TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS by O. L. Barbarash, V. V. Kashtalap

    Published 2016-02-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Risk factors for non-adherence to oral anticoagulant therapy and the potential of their modification in patients with atrial fibrillation: a narrative literature review

    Risk factors for non-adherence to oral anticoagulant therapy and the potential of their modification in patients with atrial fibrillation: a narrative literature review by I. M. Felikov, V. V. Kashtalap

    Published 2024-11-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice

    Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice by O. L. Barbarash, V. V. Kashtalap

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?

    Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? by O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring?

    Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? by D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo)

    Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Keme... by D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash

    Published 2020-01-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe

    Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe by N. V. Fedorova, V. V. Kashtalap, I. A. Shibanova, O. L. Barbarash

    Published 2021-06-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    MORTALITY FROM MYOCARDIAL INFARCTION IN RUSSIA IN THE YEARS 2006 AND 2015

    MORTALITY FROM MYOCARDIAL INFARCTION IN RUSSIA IN THE YEARS 2006 AND 2015 by I. V. Samorodskaya, О. L. Barbarash, V. V. Kashtalap, М. А. Starinskaya

    Published 2017-12-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Fundamental and practical aspects of coronary artery calcification

    Fundamental and practical aspects of coronary artery calcification by O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova, A. N. Kokov

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Predictors of ischemic and hemorrhagic complications in patients with myocardial infarction at 18-month follow-up: a single-center registry study

    Predictors of ischemic and hemorrhagic complications in patients with myocardial infarction at 18-month follow-up: a single-center registry study by V. V. Kashtalap, R. M. Velieva, D. Yu. Sedykh, O. L. Barbarash

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors

    Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors by D. Yu. Sedykh, V. V. Kashtalap, O. N. Khryachkova, T. S. Petrova, O. L. Barbarash

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome

    Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome by R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh

    Published 2020-12-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Healthy nutrition in secondary prevention after myocardial infarction. What to focus on?

    Healthy nutrition in secondary prevention after myocardial infarction. What to focus on? by O. L. Barbarash, D. Yu. Sedykh, T. S. Petrova, V. V. Kashtalap, D. P. Tsygankova

    Published 2022-01-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    CLINICAL AND PROGNOSTIC VALUE OF INTERLEUKIN-12 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

    CLINICAL AND PROGNOSTIC VALUE OF INTERLEUKIN-12 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION by M. V. Zykov, O. L. Barbarash, V. V. Kashtalap, A. V. Veremeev, L. S. Barbarash

    Published 2014-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: